According to data from the METABRIC database, patients with c-Kit overexpression showed a trend of having reduced 5-year overall survival compared to the unaltered group, but the difference was not significant ( p = 0.566) ( Figure 4 b).
← all excerpts
c-Kit Induces Migration of Triple-Negative Breast Cancer Cells and Is a Promising Target for Tyrosine Kinase Inhibitor Treatment.
1
—
—